IPOX Schuster LLC (www.ipox.com) is an innovative Financial Services Company specialized in Financial Products Design related to global New Listings (IPOs and Spin-offs). Our philosophy developed over many years of academic research in the FMG at the London School of Economics involves the classification of New Listings as a separate equity sector. Our main product are the IPOX® Indexes, patented long-only investment vehicles which are designed to capture the asset allocation potential of New Listings. With over USD 3 billions worth of IPOX-linked Financial Products launched since 2005, the indexes have become the benchmark for the peroformance of New Listings, often a pure proxy for economic growth and innovation. The IPOX 100 U.S. Index (IPXO), e.g., serves as the basis for a number of Exchange-traded-products, including CME-listed IPOX 100 U.S. Futures (Front month contract symbol: IPOZ7) or the USD million 895 million First Trust U.S. Equity Opportunities ETF (FPX). Since launch on April 13, 2006, the ETF has gained +246.04% vs. +144.10% for the ETF linked to the S&P 500 Index (SPY), main gauge for U.S. stocks.